Avoid common mistakes on your manuscript.
Correction to: Invest New Drugs (2012) 30:1434–1442
The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published in Journal of Urology in 2010 (https://doi.org/10.1016/j.juro.2010.07.035).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s10637-011-9718-1
Rights and permissions
About this article
Cite this article
Hwang, J.J., Kim, Y.S., Kim, T. et al. Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. Invest New Drugs 37, 796 (2019). https://doi.org/10.1007/s10637-019-00746-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-019-00746-y